A recent study in the Journal of Allergy and Clinical Immunology suggests that sublingual immunotherapy (SLIT) reduces the need for inhaled steroids among patients with mild to moderate allergic asthma.
Mann ENT was the first practice in North Carolina to provide sublingual immunotherapy for their patients approximately 15 years ago, and the practice has now become widespread, with major pharmaceutical companies now producing versions of this treatment for several types of common environmental allergies.
Given the increased convenience of at-home dosing, without the requirement for injections, and an improved safety profile when compared to injection immunotherapy, sublingual immunotherapy has become a mainstay of treatment for our patients. The treatment involves placing 2 drops of natural allergen proteins from nature under the tongue for 2 minutes and then swallowing. Many studies have shown the effectiveness of this treatment for control of allergy in patients of all ages, with the possibility of curing allergies over time, and reduction in the need for medications and avoidance of their common associated side effects.